CDKN2B and renal cell carcinoma: Therefore, it is not surprising that CDKN2B-AS1 can promote RCC carcinogenesis via the β-catenin pathway or function as a ceRNA for miR-141 to regulate cyclin-D1/D2 expression22,23.